Patents by Inventor Michael McCaman

Michael McCaman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Human interferon-beta formulations
    Publication number: 20050163752
    Abstract: The invention provides a stable pharmaceutical composition containing biologically active human interferon-? (IFN-?), preferably IFN ?-1b produced in a bacterial host, dissolved in an aqueous-based solution containing a glycine buffer at a pH of about 2.0 to about 4.0. The invention of also provides stable IFN-? lyophilizates prepared from biologically active IFN-?, dissolved in an aqueous-based solution containing a glycine buffer at a pH of about 2.0 to about 4.0.
    Type: Application
    Filed: February 24, 2005
    Publication date: July 28, 2005
    Inventors: Michael McCaman, Susanne Ottoboni, Erno Pungor
  • Human interferon-beta formulations
    Publication number: 20030118548
    Abstract: The invention provides a stable pharmaceutical composition containing biologically active human interferon-&bgr; (IFN-&bgr;), preferably IFN &bgr;1b produced in a bacterial host, dissolved in an aqueous-based solution containing a glycine buffer at a pH of about 2.0 to about 4.0. The invention of also provides stable IFN-&bgr; lyophilizates prepared from biologically active IFN-&bgr;, dissolved in an aqueous-based solution containing a glycine buffer at a pH of about 2.0 to about 4.0.
    Type: Application
    Filed: July 9, 2002
    Publication date: June 26, 2003
    Applicant: Schering AG
    Inventors: Michael McCaman, Susanne Ottoboni, Erno Pungor
  • Method for the production of rDSPA .alpha.1
    Patent number: 5731186
    Abstract: rDSPA .alpha.1 is produced in commercial quantities and a purity adequate for clinical standards. The production methods utilize a series of chromatographic steps: cation exchange chromatography, followed by hydrophobic interaction chromatography, and ending with affinity chromatography.
    Type: Grant
    Filed: February 5, 1996
    Date of Patent: March 24, 1998
    Assignee: Schering Aktiengesellschaft
    Inventors: Michael McCaman, Erno Pungor, Carol Souders, Mei P. Tan
  • Treponema hyodysenteriae hemolysin and uses therefor
    Patent number: 5176910
    Abstract: A vaccine for protection against swine dysentery which comprises T. hyodysenteriae hemolysin and a physiologically acceptable vehicle for said peptide. The vaccine contains the hemolysin in an amount effective for protecting against swine dysentery. The invention also relates to a method of protecting swine against swine dysentery by administering to swine the vaccine described above.
    Type: Grant
    Filed: January 17, 1989
    Date of Patent: January 5, 1993
    Assignee: ML Technology Ventures, L. P.
    Inventors: Michael McCaman, Raymond Slomiany